398 related articles for article (PubMed ID: 18201950)
1. Glial cell dysregulation: a new perspective on Alzheimer disease.
von Bernhardi R
Neurotox Res; 2007 Dec; 12(4):215-32. PubMed ID: 18201950
[TBL] [Abstract][Full Text] [Related]
2. Understanding risk factors for Alzheimer's disease: interplay of neuroinflammation, connexin-based communication and oxidative stress.
Quintanilla RA; Orellana JA; von Bernhardi R
Arch Med Res; 2012 Nov; 43(8):632-44. PubMed ID: 23142264
[TBL] [Abstract][Full Text] [Related]
3. Glial Draper Rescues Aβ Toxicity in a
Ray A; Speese SD; Logan MA
J Neurosci; 2017 Dec; 37(49):11881-11893. PubMed ID: 29109235
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model.
Grimaldi A; Brighi C; Peruzzi G; Ragozzino D; Bonanni V; Limatola C; Ruocco G; Di Angelantonio S
Cell Death Dis; 2018 Jun; 9(6):685. PubMed ID: 29880901
[TBL] [Abstract][Full Text] [Related]
5. The pathological cascade of Alzheimer's disease: the role of inflammation and its therapeutic implications.
Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
Drugs Today (Barc); 2002 Jun; 38(6):429-43. PubMed ID: 12532179
[TBL] [Abstract][Full Text] [Related]
6. Glial activation and inflammation along the Alzheimer's disease continuum.
Nordengen K; Kirsebom BE; Henjum K; Selnes P; Gísladóttir B; Wettergreen M; Torsetnes SB; Grøntvedt GR; Waterloo KK; Aarsland D; Nilsson LNG; Fladby T
J Neuroinflammation; 2019 Feb; 16(1):46. PubMed ID: 30791945
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
[TBL] [Abstract][Full Text] [Related]
8. Protection of TGF-β1 against neuroinflammation and neurodegeneration in Aβ1-42-induced Alzheimer's disease model rats.
Chen JH; Ke KF; Lu JH; Qiu YH; Peng YP
PLoS One; 2015; 10(2):e0116549. PubMed ID: 25658940
[TBL] [Abstract][Full Text] [Related]
9. Dual effects of antioxidants in neurodegeneration: direct neuroprotection against oxidative stress and indirect protection via suppression of glia-mediated inflammation.
Wang JY; Wen LL; Huang YN; Chen YT; Ku MC
Curr Pharm Des; 2006; 12(27):3521-33. PubMed ID: 17017945
[TBL] [Abstract][Full Text] [Related]
10. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
eNeuro; 2017; 4(2):. PubMed ID: 28374012
[TBL] [Abstract][Full Text] [Related]
11. Glial activation in Alzheimer's disease: the role of Abeta and its associated proteins.
Meda L; Baron P; Scarlato G
Neurobiol Aging; 2001; 22(6):885-93. PubMed ID: 11754995
[TBL] [Abstract][Full Text] [Related]
12. A 3D human triculture system modeling neurodegeneration and neuroinflammation in Alzheimer's disease.
Park J; Wetzel I; Marriott I; Dréau D; D'Avanzo C; Kim DY; Tanzi RE; Cho H
Nat Neurosci; 2018 Jul; 21(7):941-951. PubMed ID: 29950669
[TBL] [Abstract][Full Text] [Related]
13. An aging, pathology burden, and glial senescence build-up hypothesis for late onset Alzheimer's disease.
Lau V; Ramer L; Tremblay MÈ
Nat Commun; 2023 Mar; 14(1):1670. PubMed ID: 36966157
[TBL] [Abstract][Full Text] [Related]
14. Glial reaction in aging and Alzheimer's disease.
Unger JW
Microsc Res Tech; 1998 Oct; 43(1):24-8. PubMed ID: 9829455
[TBL] [Abstract][Full Text] [Related]
15. The contribution of neuroinflammation to amyloid toxicity in Alzheimer's disease.
Minter MR; Taylor JM; Crack PJ
J Neurochem; 2016 Feb; 136(3):457-74. PubMed ID: 26509334
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease.
Agostinho P; Cunha RA; Oliveira C
Curr Pharm Des; 2010; 16(25):2766-78. PubMed ID: 20698820
[TBL] [Abstract][Full Text] [Related]
17. Iron, neuroinflammation, and Alzheimer's disease.
Ong WY; Farooqui AA
J Alzheimers Dis; 2005 Nov; 8(2):183-200; discussion 209-15. PubMed ID: 16308487
[TBL] [Abstract][Full Text] [Related]
18. The cholinergic system in aging and neuronal degeneration.
Schliebs R; Arendt T
Behav Brain Res; 2011 Aug; 221(2):555-63. PubMed ID: 21145918
[TBL] [Abstract][Full Text] [Related]
19. Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.
Janota CS; Brites D; Lemere CA; Brito MA
Brain Res; 2015 Sep; 1620():153-68. PubMed ID: 25966615
[TBL] [Abstract][Full Text] [Related]
20. Aminopyridazines inhibit beta-amyloid-induced glial activation and neuronal damage in vivo.
Craft JM; Watterson DM; Frautschy SA; Van Eldik LJ
Neurobiol Aging; 2004; 25(10):1283-92. PubMed ID: 15465624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
